| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |